Oncotarget’s Post

Watch an #oncotargetshort #video about this #research paper: "Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy." https://lnkd.in/gKx6Z3R3 #cancer #trendingwithimpact #pancreaticcancer #research #oncologyresearch #openaccess #peerreviewed #publishing #meded

Watch an #oncotargetshort #video about this #research paper: "Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy." https://lnkd.in/gKx6Z3R3 #cancer #trendingwithimpact #pancreaticcancer #research #oncologyresearch #openaccess #peerreviewed #publishing #meded

The ANZUP Cancer Trials Group Limited ASM 2024 Conference Review is out! This review, accompanied by expert commentary by Associate Professor Arun Azad, features articles on; Nurse-led cardio-oncology clinic, A protein signature of metastatic relapse in prostate cancer, and many more!! Read your copy HERE: https://lnkd.in/gytKZwGg #medical #practitioners #conference #oncology #prostatecancer #urogenital #Cancer #review #research

A systematic review (DOI: 10.1097/DCR.0000000000003263) highlights neoadjuvant immunotherapy's high efficacy for mismatch repair deficient colon cancer, with 98-100% achieving complete R0 resections. The studies show a generally favorable safety profile, paving the way for new treatment protocols in a subset of colon cancer. Further research is needed to fully establish long-term outcomes and safety. #Oncology #CancerTherapy #MedicalInnovation #ClinicalStudies

Engineering M13 Bacteriophage for Targeted Photodynamic Cancer Therapy At Targeting Phage Therapy 2024, Alena Kaltenbrunner from the University of Bologna (Alma Mater Studiorum – Università di Bologna), Italy, presented an insightful oral presentation on this topic. She discussed the innovative use of the M13 bacteriophage in targeted photodynamic cancer therapy, highlighting the latest advancements in nanobiotechnology. #PhageTherapy #Nanobiotechnology #CancerTherapy #PhotodynamicTherapy #UniversityofBologna

The number of new oesophageal cancer cases annually is projected to increase by 80% before 2050. Find out about current and developing treatments set to improve patient outcomes in this article from Novotech - https://lnkd.in/gpP5uS4F #clinicaltrials #oesophagealcancer #cancer #oncology #drugdevelopment

🎖Check out the Highly cited #Review "Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies" 👥by Anurag Kumar Srivastava et al. Università degli Studi di Torino 🔗Link here: https://lnkd.in/dJfiUszd Keywords: tumor-associated antigens; cancer immunotherapy; post-translational modifications; acetylation; citrullination; phosphorylation; glycosylation

Two #pelareorep abstracts are now live at #ASCO24. A trial-in-progress for GOBLET cohort 5 in #PancreaticCancer with lead author Dirk Arnold and supported by Pancreatic Cancer Action Network. The second discussing pelareorep's MOA and ability to expand TILs across multiple #cancer indications: https://lnkd.in/gSVrgW2R #ASCO #PancreaticCancerResearch #BreastCancer #BreastCancerResearch #CancerResearch #biotech #oncology #oncolytics

This animation showcases how a specific synthetic peptide selectively targets tumor cells by forming pores in their membranes, releasing tumor-specific antigens without harming healthy cells. It clearly and concisely illustrates the mode of action (MoA) of this cancer therapy, revealing the power of immunotherapy. To learn more: https://lnkd.in/d_Czex_e #Immunotherapy #Cancer #Oncology #TumorCells #CancerTherapy #Science #SciComms #Pharma #Animation

Don’t miss Aqtual, Inc.’s poster presentation, “Detection of non-small cell lung and bladder cancer signatures in peripheral blood using a novel active chromatin capture assay,” taking place today between 9:00 AM - 12:30 PM. Session Category: Clinical Research Session Title: Circulating Nucleic Acids 4 Location: Poster Section 40; Poster Board 15 Published Abstract Number: 5028 #cfDNA #AACR24 #lungcancer #bladdercancer #oncology #PrecisionMedicine